Local view for "https://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/Evidence/741"
| Predicate | Value (sorted: default) |
|---|---|
| rdfs:label | |
| rdf:type | |
| ?:Evidence_enzyme_system | |
| ?:Evidence_numb_subjects | |
| ?:Evidence_object_dose | |
| ?:Evidence_precip_dose | |
| ?:Evidence_type | |
| ?:Evidence_value | |
| ?:content |
"Route of administration: oral
study duration: 40 participants were randomized to four groups of 10; one group of 10 received 10mg of MDZ on day followed by a washout of 2 days then participants were titrated to a dose of 200mg bid nefazodone and held at that dose until 12 days total of nefazodone treatment. On day 12 participants received a 10mg dose of MDZ.
population: 17 male, 23 female
ages:18-50
AUC_i/AUC (0-inf): 1171/257 = 4.56"
|
| dc:creator | |
| dc:date |
"11/13/2007 08:18:22"
|
| rdfs:seeAlso |
All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines/dikb.ttl
The resource appears as object in one triple:
{ nefazodone_increases_auc_midazolam, <http://purl.org/swan/1.2/swan-commons#citesAsSupportingEvidence>, evidence_1324 }